Vimarsana
Biggest News Aggregation in the World

Page 33 - Eqs Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eqs Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eqs Group Today - Breaking & Trending Today

EQS-Adhoc: Lonza Group AG: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) - Vimarsana News

EQS-Adhoc: Lonza Group AG: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)

EQS-Adhoc: Lonza Group AG: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) 06-May-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Lonza will invest approximately CHF 850 million to build two new state-of-the-art mammalian facilities and respond to customer demand regarding capacity, life cycle managemen...

EQS-Adhoc: Kuros Biosciences AG: Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion - Vimarsana News

EQS-Adhoc: Kuros Biosciences AG: Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion

EQS-Adhoc: Kuros Biosciences AG: Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion 05-May-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Grant of European patent entitled 'Pharmaceutical Formulation for Use in Spinal Fusion' Schlieren (Zurich), Switzerland, May 5, 2021 - Kuros Biosciences AG (SIX: KURN), a leader in next generation bone graft technologies, today anno...

EQS-Adhoc: Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion - Vimarsana News

EQS-Adhoc: Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion

EQS Group-Ad-hoc: Kuros Biosciences AG / Key word(s): Patent Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion 05-May-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this anno...

EQS-Adhoc: PolyPeptide Group gibt vollständige Ausübung der Mehrzuteilungsoption bekannt - Vimarsana News

EQS-Adhoc: PolyPeptide Group gibt vollständige Ausübung der Mehrzuteilungsoption bekannt

EQS Group-Ad-hoc: PolyPeptide Group / Schlagwort(e): Börsengang PolyPeptide Group gibt vollständige Ausübung der Mehrzuteilungsoption bekannt 05.05.2021 / 17:40 CET/CEST Veröffentlichung einer

EQS-News: Nordea Bank Abp: Changes in Nordea Bank Abp's own shares - Vimarsana News

EQS-News: Nordea Bank Abp: Changes in Nordea Bank Abp's own shares

EQS Group-News: Nordea Bank Abp / Key word(s): Miscellaneous Nordea Bank Abp: Changes in Nordea Bank Abp's own shares 05.05.2021 / 19:15 Changes in Nordea Bank Abp's own shares Nordea